Fiducial Markers Market Share Analysis & Forecast by Fact MR

The global fiducial markers market (基準マーカー市場) was valued at US$ 138.7 million in 2022 and is projected to reach US$ 295.6 million by 2032, growing at a compound annual growth rate (CAGR) of 7.9%.

Fiducial markers play a crucial role in medical imaging, providing reference points for accurate and precise localization of tumors or other structures during radiation therapy, surgery, and diagnostic imaging procedures. These markers are typically small, easily identifiable objects that are placed in or near the area of interest. The global fiducial markers market is driven by the increasing prevalence of cancer and the growing demand for minimally invasive procedures.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=1026

Market Dynamics:

The fiducial markers market is primarily driven by the rising incidence of cancer worldwide. According to the World Health Organization (WHO), cancer is one of the leading causes of death globally, with approximately 10 million deaths reported in 2020. Fiducial markers are widely used in radiation therapy for the precise targeting of tumors, thereby driving market growth.

Additionally, technological advancements in medical imaging and radiation therapy have contributed to the growth of the fiducial markers market. The development of advanced imaging modalities, such as MRI-guided radiation therapy, has increased the demand for fiducial markers that are compatible with these technologies.

Market Future Outlook:

The future of the fiducial markers market (기준 마커 시장) looks promising, with continued advancements in medical imaging and radiation therapy expected to drive market growth. The market is also expected to benefit from the increasing adoption of minimally invasive procedures, which require the use of fiducial markers for precise localization of tumors.

Moreover, the growing focus on personalized medicine is expected to create new opportunities for the fiducial markers market. As healthcare providers strive to deliver more targeted and effective treatments, the demand for fiducial markers that can accurately localize tumors and guide treatment delivery is expected to increase.

Market Insights:

North America dominates the fiducial markers market, owing to the presence of a well-established healthcare infrastructure and a high prevalence of cancer in the region. However, Asia-Pacific is expected to witness significant growth in the coming years, driven by the increasing adoption of advanced medical imaging technologies and the rising incidence of cancer in the region.

Key players in the fiducial markers market (marché des marqueurs fiduciaires) include CIVCO Radiotherapy, IBA Dosimetry GmbH, Boston Scientific Corporation, and Naslund Medical AB. These players are focusing on product innovation and strategic partnerships to strengthen their market presence.

Key Players:

• Eckert & Ziegler BEBIG
• Innovative Oncology Solutions
• Boston Scientific
• IBA Dosimetry
• Best Medical International, Inc.
• IZI Medical Products
• Carbon Medical Technologies
• CIVCO
• alphaXRT

Competitive Landscape:

Many fiducial marker manufacturers are expanding their product lines, with a focus on marketing through online channels to reach a wider customer base. This approach is expected to drive market growth.

In 2020, Innovative Oncology Solutions introduced new fiducial markers including SBRT Immobilization, Supine Breast & Thorax Positioning, among others. Similarly, CIVCO launched a new range of fiducial markers such as Solstice™ MR SRS Immobilization System, Monarch™ Vac-Lok™ Options, and others.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=1026

Segmentation of Fiducial Marker Industry Research

• By Product Type :
• Polymer-based Markers
• Metal-based Markers
• Pure Gold Markers
• Liquid-based Markers
• By Modality :
• Photon Therapy
• Proton Therapy
• Tomotherapy
• Cyberknife
• By Disease Site :
• Head & Neck
• Breast
• Lung
• Abdomen
• Prostate
• Kidney
• Cervix or Other Gynaecologic Organs
• By End User :
• Hospitals
• Cancer Research Institutes
• Radiotherapy Centers
• By Region :
• North America
• Latin America
• Europe
• East Asia
• South Asia & ASEAN
• Oceania
• MEA

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com